Adam Rogers Selected Research

Mineralocorticoids

1/2019

Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam Rogers Research Topics

Disease

1	Coinfection 10/2023
1	Central Serous Chorioretinopathy 01/2019
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2016
1	Bites and Stings (Sting) 07/2011
1	Diabetic Neuropathies (Diabetic Neuropathy) 04/2009
1	Polyneuropathies (Polyneuropathy) 04/2009
1	Atrophy 12/2007
1	North Carolina type 1 retinal Macular dystrophy 12/2007

Drug/Important Bio-Agent (IBA)

1	RNA (Ribonucleic Acid)IBA 10/2023
1	MineralocorticoidsIBA 01/2019
1	Eplerenone (Inspra)FDA LinkGeneric 01/2019
1	Retinaldehyde (Retinal)IBA 01/2016
1	QuartzIBA 07/2011
1	Thrombin FDA Link 07/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009
1	Retinal Pigments (Pigments, Visual)IBA 12/2007

Therapy/Procedure

1	Therapeutics 01/2019
1	Injections 04/2009